Ticker Details
Rein Therapeutics, Inc. Common Stock
IPO Date:	August 26, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$42.9M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.07 | 4.44%
Avg Daily Range (30 D):	$0.06 | 4.35%
Avg Daily Range (90 D):	$0.05 | 4.02%

Institutional Daily Volume
Avg Daily Volume:	.05M
Avg Daily Volume (30 D):	.08M
Avg Daily Volume (90 D):	.12M

Trade Size
Avg Trade Size (Sh.):	151
Avg Trade Size (Sh.) (30 D):	172
Avg Trade Size (Sh.) (90 D):	190

Institutional Trades
Total Institutional Trades:	2
Avg Institutional Trade:	$.63M
Avg Institutional Trade (30 D):	$.68M
Avg Institutional Trade (90 D):	$.68M
Avg Institutional Trade Volume:	.5M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	K

News

Feb 9, 2026 @ 6:00 PM Idiopathic Pulmonary Fibrosis Clinical Trials & Pi... Source: Delveinsight

Aug 19, 2025 @ 12:00 PM Rein Therapeutics Wins U.K. Approval to Launch Pha... Source: Rein Therapeutics

Aug 14, 2025 @ 9:00 PM Rein Therapeutics to Present Novel IPF Science and... Source: Rein Therapeutics

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.96	$-1.22	$-1.96
Diluted EPS	$-1.96	$-1.22	$-1.96
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-49.87M	$-31.97M	$-49.87M
Operating Income / Loss	$-50.63M	$-32.66M	$-50.63M
Cost of Revenue
Net Cash Flow	$.04M	$.02M	$.04M
PE Ratio